CORC

在结果中检索

CORC

浏览/检索结果: 共21条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Nedaplatin and paclitaxel compared with carboplatin and paclitaxel for patients with platinum-sensitive recurrent ovarian cancer 期刊论文
2018, 卷号: 8, 期号: 6, 页码: 1074-1082
作者:  Ge, Li;  Li, Ning;  Yuan, Guang-Wen;  Sun, Yang-Chun;  Wu, Ling-Ying
收藏  |  浏览/下载：11/0  |  提交时间：2020/01/03
Paclitaxel plus nedaplatin vs. paclitaxel plus carboplatin in women with epithelial ovarian cancer: A multi-center, randomized, open-label, phase III trial 期刊论文
2018, 卷号: 15, 期号: 3, 页码: 3646-3652
作者:  Li, Li;  Zhuang, Qingqing;  Cao, Zeyi;  Yin, Rutie;  Zhu, Yaping
收藏  |  浏览/下载：2/0  |  提交时间：2020/01/03
Etoposide and cisplatin versus paclitaxel and carboplatin with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer: a multicenter randomized phase III trial 期刊论文
2017, 卷号: 28, 期号: 4, 页码: 777-783
作者:  Liang, J.;  Bi, N.;  Wu, S.;  Chen, M.;  Lv, C.
收藏  |  浏览/下载：7/0  |  提交时间：2020/01/03
Response to 'Survival advantage for etoposide/ cisplatin over paclitaxel/carboplatin concurrent chemoradiation in patients with inoperable stage III NSCLC: a subgroup analysis for ECOG 2 patients would be of great interest' 期刊论文
2017, 卷号: 28, 期号: 12, 页码: 3101-3103
作者:  Bi, N.;  Liang, J.;  Wang, L.
收藏  |  浏览/下载：2/0  |  提交时间：2020/01/03
Efficacy and safety of the combination of paclitaxel and platinum in advanced thymic carcinoma 期刊论文
2016, 卷号: 7, 期号: 2, 页码: 222-225
作者:  Xu, Jian-ping;  Hao, Xue-zhi;  Zhang, Xiang-ru;  Yang, Sheng;  Shi, Yuan-kai
收藏  |  浏览/下载：1/0  |  提交时间：2020/01/04
A phase I trial of an oral subtype-selective histone deacetylase inhibitor, chidamide, in combination with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer 期刊论文
2016, 卷号: 28, 期号: 4, 页码: 444-451
作者:  Hu, Xingsheng;  Wang, Lin;  Lin, Lin;  Han, Xiaohong;  Dou, Guifang
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04
A phase I trial of an oral subtype-selective histone deacetylase inhibitor,chidamide,in combination with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer 期刊论文
2016, 卷号: 28, 期号: 4, 页码: 444-451
作者:  Hu Xingsheng;  Wang Lin;  Lin Lin;  Han Xiaohong;  Dou Guifang
收藏  |  浏览/下载：8/0  |  提交时间：2020/01/04
Better pathologic complete response and relapse-free survival after carboplatin plus paclitaxel compared with epirubicin plus paclitaxel as neoadjuvant chemotherapy for locally advanced triple-negative breast cancer: a randomized phase 2 trial 期刊论文
2016, 卷号: 7, 期号: 37, 页码: 60647-60656
作者:  Zhang, Pin;  Yin, Yi;  Mo, Hongnan;  Zhang, Bailin;  Wang, Xiang
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04
Efficacy and safety analysis of trastuzumab and paclitaxel based regimen plus carboplatin or epirubicin as neoadjuvant therapy for clinical stage II-III, HER2-positive breast cancer patients: a phase 2, open-label, multicenter, randomized trial 期刊论文
2015, 卷号: 6, 期号: 21, 页码: 18683-18692
作者:  Huang, Liang;  Chen, Sheng;  Yang, Wentao;  Xu, Binghe;  Huang, Tao
收藏  |  浏览/下载：2/0  |  提交时间：2020/01/13
Phase II trial of paclitaxel-carboplatin with intercalated gefitinib for untreated, epidermal growth factor receptor gene mutation status unknown non-small cell lung cancer 期刊论文
2014, 卷号: 5, 期号: 2, 页码: 149-154
作者:  Yang, Jianliang;  Shi, Yuankai;  Zhang, Xiangru;  Xu, Jianping;  Wang, Bin
收藏  |  浏览/下载：2/0  |  提交时间：2020/01/13

©版权所有 ©2017 CSpace - Powered by CSpace